Where is Zenas headquartered?

Zenas is located in Waltham, MA.

Who invested in Zenas?

Zenas has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Zenas?

Zenas closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

zenasbio.com

Zenas

Zenas is a Massachusetts-based biopharmaceutical company that researches and develops immuno-therapeutics for the treatment of autoimmune and rare diseases.

Business Model:

Revenue: $6M

Employees: 51-200

Geographic Data

Address: 1000 Winter St

City: Waltham

State: MA

Zip: 02451

Country: US

Financial Info

Stage:

series b

Raised Last:

$118M

Raised Total:

$118M

Social

Twitter

Crunchbase

Metrics

3,573,498Website Global Rank

3,182Website Monthly Traffic

Twitter Followers

Description

Zenas is a Massachusetts-based biopharmaceutical company that researches and develops immuno-therapeutics for the treatment of autoimmune and rare diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2021	Series A		-	Fairmount Funds Management Quan Capital Tellus BioVentures Wellington Management WuXi Healthcare Ventures Fairmount Funds Management Quan Capital Tellus BioVentures Wellington Management WuXi Healthcare Ventures
11/2022	Series B		$0	Agent Capital Enavate Sciences Fairmount Funds Management Longitude Capital Perceptive Advisors Pivotal bioVenture Partners Quan Capital Rock Springs Capital Superstring Capital Tellus BioVentures Vivo Capital Wellington Management Xencor Agent Capital Enavate Sciences Fairmount Funds Management Longitude Capital Perceptive Advisors Pivotal bioVenture Partners Quan Capital Rock Springs Capital Superstring Capital Tellus BioVentures Vivo Capital Wellington Management Xencor
11/2022	Series B	13	$118M	Enavate Sciences Longitude Capital Vivo Capital Rock Springs Capital Perceptive Advisors Agent Capital Pivotal bioVenture Partners Superstring Capital Fairmount Wellington Management Tellus BioVentures Quan Venture Fund Xencor Agent Capital Enavate Sciences Fairmount Funds Management Longitude Capital Perceptive Advisors Pivotal bioVenture Partners Quan Capital Rock Springs Capital Superstring Capital Tellus BioVentures Vivo Capital Wellington Management Xencor
3/2021	Series A	5	-	Fairmount Funds Management Quan Capital Tellus BioVentures Wellington Management WuXi Healthcare Ventures Fairmount Funds Management Quan Capital Tellus BioVentures Wellington Management WuXi Healthcare Ventures

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details